GERN Shares Outstanding History



Below is a table of the GERN shares outstanding history going back to 2/23/2010:

Date GERN Shares Outstanding
2/23/2010103.11M
4/26/2010103.88M
7/26/2010107.84M
10/25/2010108.54M
2/22/2011136.25M
4/25/2011136.47M
7/25/2011139.05M
10/24/2011139.10M
2/22/2012140.17M
4/30/2012139.75M
7/30/2012138.87M
10/29/2012138.34M
3/1/2013138.15M
4/29/2013137.99M
8/1/2013136.11M
11/1/2013136.45M
3/6/2014166.00M
4/25/2014166.04M
8/4/2014156.88M
10/31/2014157.21M
3/6/2015157.70M
4/30/2015158.09M
7/31/2015158.14M
10/30/2015158.22M
3/3/2016158.92M
4/29/2016158.96M
7/29/2016159.14M
10/28/2016159.15M
2/21/2017159.16M
5/1/2017159.18M
8/2/2017159.21M
10/25/2017159.23M
3/7/2018160.65M
5/3/2018173.08M
7/24/2018183.62M
10/25/2018186.35M
3/1/2019186.39M
4/29/2019186.52M
7/26/2019188.42M
7/30/2019239.81M
11/1/2019199.78M
3/2/2020200.34M
7/31/2020310.47M
11/2/2020310.47M
3/1/2021318.53M
5/4/2021318.57M
8/11/2021320.60M
11/4/2021321.95M
3/1/2022323.73M
5/3/2022377.45M
9/30/2022381.24M
3/9/2023508.72M
5/5/2023508.77M
7/27/2023523.37M
10/31/2023543.06M
2/23/2024546.06M

Also see: GERN Market Cap History
GERN YTD Return
GERN Historical Shares Outstanding:
+12.64% CAGR
GERN Historical Shares Outstanding: +12.64% CAGR

Mouse over chart for data details
2/23/2010 ...2/23/2024
Geron is a biopharmaceutical company that is focused on the development and commercialization of imetelstat, a telomerase inhibitor. Co. is conducting two ongoing Phase 3 clinical trials that are designed to enable registration of imetelstat: (i) IMerge Phase 3 in lower risk myelodysplastic syndromes (MDS), and (ii) IMpactMF in refractory myelofibrosis (MF). Imetelstat has been granted Fast Track designations by the U.S. Food and Drug Administration for the treatment of patients with transfusion-dependent anemia due to lower risk MDS and who are refractory or resistant to treatment with an erythropoiesis stimulating agent and for the treatment of patients with MF. We show 56 historical shares outstanding datapoints in our coverage of GERN's shares outstanding history.

Understanding the changing numbers of GERN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GERN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GERN by allowing them to research GERN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree GERN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Geron (GERN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

GFOR Shares Outstanding History
GH Shares Outstanding History
GHDX Shares Outstanding History
GILD Shares Outstanding History
GKOS Shares Outstanding History
GLSI Shares Outstanding History
GLTO Shares Outstanding History
GLUE Shares Outstanding History
GLYC Shares Outstanding History
GMED Shares Outstanding History
More Healthcare companies »

 

GERN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.